BioWV Forum: Status of COVID-19 Vaccines in Development & WV’s Implementation Plan
Phyllis Arthur, Vice President for Infectious Diseases and Diagnostics Policy, Biotechnology Innovation Organization (BIO)
“Striking” and “unprecedented” are just a few terms to describe the amazing speed with which America’s biopharmaceutical industry and the global research community have responded in working to develop vaccines and treatments for COVID-19. For its part, the State of West Virginia has been nationally recognized for its management of, and response to the virus.
Please join the Bioscience Association of West Virginia (BioWV) for an informative and educational presentation on the status of vaccines and therapeutics in development to combat COVID-19 and the plan for rolling out the vaccine(s) in West Virginia, once available. The event, to be held virtually, will take place from 2-3pm on Tuesday, November 10th.
The event will feature Phyllis Arthur, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization (BIO), and Dr. Clay Marsh, Vice President & Executive Dean for Health Sciences at West Virginia University and COVID-19 Czar for the State of West Virginia. To register, click here.
Ms. Arthur is an organizational lead on COVID-19 response for BIO, responsible for working with member companies in vaccines, antimicrobial resistance, molecular diagnostics and biodefense on policy, legislative and regulatory issues.
Dr. Marsh, in his role as COVID-19 Czar, coordinates the state’s response to the challenges of the new coronavirus, collaborating with federal, state, and local agencies,
Dr. Clay Marsh, VP & Executive Dean for Health Sciences at WVU and WV COVID-19 Czar
health officials, researchers and other agencies helping with the effort.
Special thanks and appreciation to our event sponsors: Mylan, VWR, BIO, PhRMA, Pfizer, Novartis and Advantage Technologies.